Last reviewed: June 10, 2026
Last updated: June 10, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Tirzepatide, a dual GLP-1 and GIP receptor agonist, has become increasingly popular for weight loss management. Some patients report concerns about hair shedding during early treatment, but understanding the mechanism and prevalence can help you make an informed decision about your weight loss journey.
Is Hair Loss a Known Side Effect of Tirzepatide?
Hair loss is not officially listed as a primary side effect in tirzepatide clinical trials. The SURMOUNT-1, SURMOUNT-2, and SURMOUNT-3 trials tracking over 2,500 patients reported gastrointestinal symptoms, nausea, and injection site reactions as the most common adverse effects. Hair shedding occurred at low frequencies in trial populations, making it uncommon rather than expected.
When hair loss does occur during tirzepatide treatment, it typically develops within the first 2-3 months as your body undergoes rapid metabolic changes. This pattern suggests the shedding is more likely tied to weight loss itself rather than the medication, a phenomenon called telogen effluvium that can follow any significant caloric deficit.
Telogen Effluvium: Why Weight Loss Affects Hair Growth
Telogen effluvium is a temporary hair shedding condition triggered by stress on your body, including rapid weight loss, nutritional changes, or hormonal shifts. During significant weight reduction, your hair follicles can shift prematurely from the growth phase into the shedding phase, resulting in increased hair loss that typically resolves within 3-6 months.
Tirzepatide works by suppressing appetite and slowing gastric emptying, which can lead to lower calorie intake and faster weight loss compared to diet alone. This accelerated weight reduction, rather than the medication itself, may trigger telogen effluvium in genetically predisposed individuals. Maintaining adequate protein intake, micronutrients, and a measured weight loss pace can reduce your risk.
Nutritional Factors and Hair Loss During GLP-1 Therapy
Patients on tirzepatide often experience reduced appetite and nausea, which can make it harder to consume enough protein, iron, zinc, and B vitamins—all essential for healthy hair growth. Deficiencies in these micronutrients can independently trigger or worsen hair shedding, particularly if weight loss is rapid. PlexusDx recommends discussing nutrition with a healthcare provider to ensure you're meeting baseline micronutrient needs during treatment.
Hair follicles are sensitive to amino acid availability and iron status. If your tirzepatide therapy results in consuming fewer calories but also fewer nutrient-dense foods, your body may redirect limited amino acids toward maintaining vital organs rather than hair synthesis. Prioritizing high-protein meals when appetite allows and considering targeted supplementation can support hair health during your weight loss journey.
Genetic Predisposition to Hair Loss and Peptide Therapy
Individual responses to tirzepatide—including susceptibility to hair shedding—are influenced by genetic factors that affect peptide signaling pathways. PlexusDx Precision Peptide Genetic Test analyzes key variants including GLP1R rs6923761, GIPR rs1800437, and others that modulate how your body responds to GLP-1 and GIP receptor activation. Understanding your genetic profile can help predict which patients are more likely to experience metabolic stress during treatment.
Patients with genetic variants associated with increased appetite signaling or altered nutrient metabolism may be more prone to rapid weight loss and secondary telogen effluvium. PlexusDx uses peptide-pathway genetic insights to identify these patterns and allows your clinical team to personalize dosing, pacing, and nutritional support. The Precision Peptide Genetic Test ($99 add-on after your first month) maps 14 metabolic pathways and 150+ genetic insights to optimize your treatment plan.
What You Should Monitor and When to Contact Your Provider
Track your hair shedding during the first 3-6 months of tirzepatide treatment to establish a baseline. Normal daily hair loss ranges from 50-100 strands; noticeable increases beyond this or visible thinning patches warrant a conversation with your PlexusDx clinical team. Documenting timing, severity, and any coinciding nutritional or lifestyle changes helps your provider distinguish telogen effluvium from other causes.
Contact your healthcare provider if hair loss persists beyond 6 months, worsens despite stable weight, or occurs alongside other symptoms like fatigue or nail brittleness—signs that may indicate nutritional deficiency. PlexusDx providers can adjust your treatment plan, recommend supplementation, or coordinate care with dermatology if needed. Most cases of medication-related hair shedding resolve completely once your body adapts to your new weight and metabolism stabilizes.
Managing Hair Health While on Compounded Tirzepatide
Maintain a gradual weight loss pace rather than extreme caloric restriction to minimize metabolic stress and telogen effluvium risk. PlexusDx compounded tirzepatide injections start at $249/mo—your dose may need to go up as your treatment progresses, but your price won't. Working with your clinical team to find the lowest effective dose reduces the speed of weight loss and allows your body time to adapt, protecting hair and overall health.
Prioritize protein intake, iron-rich foods, and zinc during tirzepatide therapy. Biotin, collagen peptides, and vitamin D supplementation have evidence supporting hair strength, though they won't prevent telogen effluvium triggered by rapid weight loss. If nausea limits your food intake, meal replacement shakes or bone broth can deliver protein and micronutrients in easier-to-tolerate forms. Your PlexusDx provider can discuss these strategies during your ongoing care.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can tirzepatide directly cause permanent hair loss?
Clinical trial data shows tirzepatide does not directly cause permanent hair loss. Shedding that occurs during treatment is typically telogen effluvium—temporary hair loss triggered by rapid weight loss or nutritional changes—which resolves within 3-6 months as your body stabilizes.
How common is hair loss among patients taking tirzepatide?
Hair shedding is reported by a small subset of tirzepatide users and is not listed as a primary adverse effect in SURMOUNT trials. Most patients do not experience noticeable hair loss, and when it occurs, it is usually mild and temporary, correlating with the pace of weight loss rather than the medication itself.
What should I do if I notice hair loss after starting tirzepatide?
Monitor your shedding for 2-3 months while documenting your weight loss pace and nutrition intake. Contact your PlexusDx provider if shedding increases significantly or persists beyond 6 months. Your clinical team can recommend micronutrient supplementation, adjust your treatment pacing, or coordinate specialty care.
Does PlexusDx compounded tirzepatide have different hair loss risks than brand-name Mounjaro?
Compounded tirzepatide from licensed 503A pharmacies contains the same active ingredient as brand-name formulations and carries equivalent safety profiles. PlexusDx compounded tirzepatide injections start at $249/mo with no flat per-compound pricing changes, and all patients receive clinical oversight to monitor side effects and adjust treatment as needed.
Can the Precision Peptide Genetic Test predict if I'll lose hair on tirzepatide?
PlexusDx Precision Peptide Genetic Test analyzes 150+ genetic insights across 14 metabolic pathways, including variants affecting nutrient absorption and weight loss pace. While it cannot directly predict hair loss, it can identify genetic predispositions to rapid metabolism or nutrient sensitivity that increase telogen effluvium risk, allowing personalized preventive strategies.
Is tirzepatide safe for people with existing hair loss conditions?
Tirzepatide is safe for people with androgenetic alopecia or other baseline hair loss conditions, though rapid weight loss may temporarily worsen shedding. Discuss your hair loss history with your PlexusDx clinical team before starting treatment so they can implement nutritional support and monitor your response carefully.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Understanding What Happens If You Use Expired GLP-1 Medications
Can Ozempic Help With Inflammation? The Surprising Systemic Benefits of GLP-1 Therapy